NEW YORK, Sept. 5, 2022 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, is reminding buyers of purchases of Enochian BioSciences, Inc. (NASDAQ: ENOB) between January 17, 2018 and June 27, 2022, both dates including (the “Class Period”) securities, including privately placed common shares issued by Enochian on or about February 16, 2018, September 26, 2022 Important date for lead plaintiff’s deadline.
What: If you have purchased Enochian BioSciences securities during a class action lawsuit, you may be entitled to compensation without paying out-of-pocket expenses or costs incurred under contingency fee arrangements.
Next Step: To participate in the Enochian BioSciences class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6517 Or call Mr. Phillip Kim toll free: 866-767-3653 or email: [email protected] or [email protected] Learn more about class action lawsuits. A class action lawsuit has been filed. If you wish to be a lead plaintiff, you must do so On or before September 26, 2022Apply to the court. Lead Plaintiff is the representative who directs the proceeding on behalf of the other members of the class.
Why choose ROSEN LAW:We recommend investors to select qualified legal advisors with a successful track record in senior positions. Often, the law firm issuing the notice does not have comparable experience, resources, or meaningful peer recognition.Many of these law firms do not actually conduct securities class actions, but are merely intermediaries referring clients or working with the law firm that actually files the lawsuit.Be wise when choosing a lawyer. The Law Firm of Rosen represents global investors with a focus on securities class action lawsuits and shareholder derivatives lawsuits. Law firm Rosen reaches the largest-ever settlement in a securities class action lawsuit against a Chinese company. In 2017, ISS Securities Class Action Services ranked Rosen Law Firm #1 for the number of securities class action settlements. The company has ranked in the top four every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company has more than…
Continue to read on GlobeNewswire https://www.globenewswire.com/news-release/2022/09/05/2509555/673/zh-hant/%E9%A0%82%E5%B0%96%E6%B3%95%E5%BE%8B%E4%BA%8B%E5%8B%99%E6%89%80-ROSEN-%E9%BC%93%E5%8B%B5%E8%92%99%E5%8F%97%E8%99%A7%E6%90%8D%E7%9A%84-Enochian-BioSciences-Inc-%E6%8A%95%E8%B3%87%E8%80%85%E5%9C%A8%E8%AD%89%E5%88%B8%E9%9B%86%E9%AB%94%E8%A8%B4%E8%A8%9F%E7%9A%84%E9%87%8D%E8%A6%81%E6%88%AA%E6%AD%A2%E6%97%A5%E6%9C%9F%E5%89%8D%E5%B0%8B%E6%B1%82%E6%B3%95%E5%BE%8B%E6%84%8F%E8%A6%8B-ENOB.html
